[HTML][HTML] COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
A Fendler, EGE de Vries… - Nature Reviews …, 2022 - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …
associated mortality than the general population. Owing to this increased risk, patients with …
[HTML][HTML] Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Host genetic and environmental factors including age, biological sex, diet, geographical
location, microbiome composition and metabolites converge to influence innate and …
location, microbiome composition and metabolites converge to influence innate and …
Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review
MCR Fernandes, GS Vasconcelos, ACL de Melo… - Molecular …, 2023 - Elsevier
Vaccines induce specific long-term immunological memory against pathogens, preventing
the worsening of diseases. The COVID-19 health emergency has caused more than 6 …
the worsening of diseases. The COVID-19 health emergency has caused more than 6 …
Learning through a pandemic: the current state of knowledge on COVID-19 and cancer
The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …
or past history of cancer facing disparate consequences at every stage of the cancer …
[HTML][HTML] Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients …
N Uaprasert, P Pitakkitnukun… - Blood Cancer …, 2022 - nature.com
Patients with hematologic malignancies (HM) have demonstrated impaired immune
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
[HTML][HTML] Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
V Piechotta, SC Mellinghoff, C Hirsch… - Blood Cancer …, 2022 - nature.com
The efficacy of SARS-CoV-2 vaccination in patients with hematological malignancies (HM)
appears limited due to disease and treatment-associated immune impairment. We …
appears limited due to disease and treatment-associated immune impairment. We …
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
SV Retnakumar, C Chauvin, J Bayry - Pharmacology & therapeutics, 2023 - Elsevier
The phenomenon of 'T cell exhaustion', a state of T cell dysfunction observed during chronic
infections and cancers, has been a major obstacle in mounting appropriate immune …
infections and cancers, has been a major obstacle in mounting appropriate immune …
[HTML][HTML] Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
H Kakkassery, E Carpenter, PEM Patten… - Trends in Molecular …, 2022 - cell.com
Transmission of the SARS-CoV-2 virus and its corresponding disease (COVID-19) has been
shown to impose a higher burden on cancer patients than on the general population …
shown to impose a higher burden on cancer patients than on the general population …
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological …
M Noori, S Azizi, FA Varaki, SA Nejadghaderi… - International …, 2022 - Elsevier
Background Cancer patients particularly those with hematological malignancies are at
higher risk of affecting by severe coronavirus disease 2019 (COVID-19). Due to the …
higher risk of affecting by severe coronavirus disease 2019 (COVID-19). Due to the …
[HTML][HTML] Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di …
P Pedrazzoli, A Lasagna, I Cassaniti, A Piralla… - ESMO open, 2023 - Elsevier
Highlights•VPDs represent a serious issue for cancer patients.•The AIOM has been involved
in vaccination awareness since 2014.•Seasonal flu, pneumococcal and anti-SARS-CoV-2 …
in vaccination awareness since 2014.•Seasonal flu, pneumococcal and anti-SARS-CoV-2 …